影响HIV-1蛋白酶抑制剂结合的因素:来自机器学习模型的见解
Yaffa Shalit1, Inbal Tuvi-Arad1
1Department of Natural Sciences, The Open University of Israel, Raanana, 4353701, Israel.
ChemMedChem
|May 28, 2025
概括
机器学习模型使用结构数据预测HIV-1蛋白酶抑制剂的有效性. 这种方法提高了对抗病毒药物相互作用的理解,并有助于开发获得性免疫缺陷综合征的新疗法.
科学领域:
- 结构生物学是结构生物学.
- 计算化学是一种计算化学.
- 药物发现 药物发现
背景情况:
- 艾滋病毒-1蛋白酶 (PR) 抑制剂对于获得性免疫缺陷综合征 (AIDS) 抗病毒疗法至关重要.
- 许多PR抑制剂复合物具有结构性特征,但缺乏具有约束力的亲和力数据,限制了有效性评估.
- 这种数据缺口阻碍了对抑制剂疗效的全面理解.
研究的目的:
- 开发和验证用于预测HIV-1蛋白酶抑制剂结合亲和力的机器学习模型.
- 通过结晶学数据识别影响抑制剂疗效的关键分子特征.
- 为了弥合PR-抑制剂复合物的实验性结合亲和度测量的差距.
主要方法:
- 使用291个PR抑制剂复合物的晶体坐标构建和验证机器学习模型.
- 利用超过2500个分子描述符进行模型训练.
- 分析了三种不同的模型:随机森林的KBest,随机森林的递归特征消除和支持向量机的顺序特征选择.
主要成果:
- 机器学习模型的准确性得分超过了0.85.
- 对274种缺乏实验数据的其他PR抑制剂复合物预测的结合亲缘关系.
- 确定了关键的预测特征,包括抑制器电荷分布,结,3D拓和PR活性位点对称性和突变.
结论:
- 机器学习从结构数据准确地预测HIV-1蛋白酶抑制剂的结合亲和力.
- 抑制剂和蛋白酶的结构和化学特性对于疗效至关重要.
- 这种方法增强了结构性理解,并支持开发新型抗病毒疗法.
相关概念视频
Factors Affecting Protein-Drug Binding: Protein-Related Factors
280
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
280
Factors Affecting Protein-Drug Binding: Drug-Related Factors
217
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
217
Factors Affecting Protein-Drug Binding: Patient-Related Factors
123
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
123
Protein-protein Interfaces
13.8K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.8K
Factors Affecting Protein-Drug Binding: Drug Interactions
292
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
292
Protein-Drug Binding: Determination Methods
325
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
325


